CFTR and cystic fibrosis: A sex gap was observed in CF patients' response to ivacaftor, a CFTR (CF transmembrane conductance regulator) modulator: although there was no significant sex difference in FEV-1 improvement, ivacaftor-treated women showed greater reduction in pulmonary exacerbation and in sweat chloride than men (25).